UK markets close in 4 hours 3 minutes

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
77.23+0.62 (+0.81%)
At close: 4:02PM EDT
77.02 -0.21 (-0.27%)
Pre-market: 07:23AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close76.61
Open76.34
Bid76.40 x 1800
Ask77.25 x 3000
Day's range75.99 - 77.46
52-week range68.44 - 83.78
Volume14,048,986
Avg. volume12,784,020
Market cap195.551B
Beta (5Y monthly)0.41
PE ratio (TTM)27.89
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield2.60 (3.37%)
Ex-dividend date14 Jun 2021
1y target estN/A
  • Editor's pick
    Yahoo Finance Video

    Affordable Care Act survives third Supreme Court challenge

    Andy Slavitt, former White House COVID-19 Response Team adviser, author of ‘PREVENTABLE: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response’, joins Yahoo Finance to discuss the COVID-19 response in the U.S. and the Supreme court upholding the Affordable Care Act.

  • This Biopharma Giant May Have Just Found Its Ticket To Riches In the COVID-19 Market
    Motley Fool

    This Biopharma Giant May Have Just Found Its Ticket To Riches In the COVID-19 Market

    After a long year and a half spent enduring the coronavirus pandemic, signs of normalcy are starting to show in many U.S. businesses and communities, thanks in part to pharmaceutical breakthroughs including vaccines. After two previously failed attempts to develop new antiviral treatments, biopharma giant Merck (NYSE: MRK) has come up with something it believes will provide care for those in need. Specifically, Merck has been collaborating with Ridgeback Biotherapeutics on a clinical development program for molnupiravir, an oral antiviral medication.

  • Yahoo Finance Video

    Influencers with Andy Serwer: David Ricks

    In this episode of Influencers, Eli Lilly Chairman & CEO David Ricks joins Andy to discuss the latest in the pharmaceutical industry, new progress in the fight against COVID-19, and potential groundbreaking advancements for the treatment of Alzheimer’s.